NCT02031445View on ClinicalTrials.gov

Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%

PHASE2TerminatedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Atopic Dermatitis
Interventions
DRUG

MRX-6

OTHER

Placebo

Trial Locations (5)

64239

Sourasky Medical Center, Tel Aviv

Unknown

Dermatology Clinic, Kfar Saba

Dermatology Clinic, Kiryat Ono

Lev Yasmin Clinic, Netanya

Dermatology Clinic, Petah Tikva

Sponsors
All Listed Sponsors
lead

Celsus Therapeutics PLC

INDUSTRY